Date:18-May-2024  Time: 11:22 PM
 
 
        
Glenmark Life Sciences Ltd
Quarters:       (Rs. In Crores)
ParticularsMar 2024Dec 2023Sep 2023Jun 2023
Type4Qtr3Qtr2Qtr1Qtr
Net Sales536.60572.80595.36578.45
Other Income3.131.695.371.85
Total Income539.73574.50600.73580.30
Total Expenditure 395.15400.25428.28385.29
Operating Profit144.58174.25172.45195.01
Interest0.360.390.400.40
Gross Profit144.21173.86172.05194.62
Depreciation14.5313.1813.1312.61
Tax31.0538.8638.7043.60
Deferred Tax0.693.061.492.96
Reported Profit After Tax97.94118.77118.74135.45
Source:Capital Market
 
Useful linksNSEIBSEI SEBIINSDLI NCDEXI CDSLIRBI      Careers | Feedback | Sitemap | Disclaimer | Privacy Policy | Grievances
Sebi Reg No: NSE INB231168734(CM) INF231168734(F&O) Sebi Reg No: BSE INB011168730 INF011168730   NCDEX: Membership Code: 00774
MCX: Membership Code: 31560  Mutual Funds: ARN0843.
FMC Unique Membership Code: MCX/TCM/CORP/1106
2006-07 © Senator Securities Pvt. Ltd. All rights reserved
FMC Unique Membership Code: NCDEX/TCM/CORP/0760
Design, developed & maintained by C-MOTS Infotech(ISO 9001:2000 certified)
Content powered by capitalmarket.com